Ignite Creation Date:
2025-12-24 @ 1:41 PM
Ignite Modification Date:
2026-01-03 @ 9:16 PM
Study NCT ID:
NCT02045095
Status:
TERMINATED
Last Update Posted:
2019-03-14
First Post:
2013-12-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Dose Escalation Study of MLN7243 (TAK-243) in Adult Participants With Advanced Solid Tumors
Sponsor:
Millennium Pharmaceuticals, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-01-31
Start Date Type:
ACTUAL
Primary Completion Date:
2016-11-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2016-11-09
Completion Date Type:
ACTUAL
First Submit Date:
2013-12-18
First Submit QC Date:
None
Study First Post Date:
2014-01-24
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2017-11-06
Results First Submit QC Date:
None
Results First Post Date:
2019-03-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-11-28
Last Update Post Date:
2019-03-14
Last Update Post Date Type:
ACTUAL